Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Natural Vitamin K2 Supplement MenaQ7 Shown to be Superior to K1 in A New Human Study in the Journal Blood
Scientists at the Cardiovascular Research Institute (CARIM) and VitaK, Maastricht University, The Netherlands, demonstrated a significant superiority of Natural Vitamin K2 as Mk-7 in four different human models. They cited the major difference between the vitamin K species as the very long half-life time of Mk-7, which results in much more stable blood levels and 7 to 8 times greater accumulation of Mk-7 in the blood. Mk-7 also more effectively promoted and activated markers of bone building and showed a marked advantage against vitamin K antagonists.
- New Study Shows Walnuts Improve Bone Health
In a study published in the journal Nutrition, research suggests walnuts, rich in alpha-linolenic acid (ALA), an essential omega-3 fatty acid, are beneficial to the skeletal system by decreasing the breakdown of bone.
- New Study Shows Walnuts Improve Bone Health
In a study published in the journal Nutrition, research suggests walnuts, rich in alpha-linolenic acid (ALA), an essential omega-3 fatty acid, are beneficial to the skeletal system by decreasing the breakdown of bone.
- New Study Shows Walnuts Improve Bone Health
In a study published in the journal Nutrition, research suggests walnuts, rich in alpha-linolenic acid (ALA), an essential omega-3 fatty acid, are beneficial to the skeletal system by decreasing the breakdown of bone.
- study In Osteoporosis International Indicates Vitamin K2 Supplementation Improves Hip Bone Geometry and Bone Strength Indices in Postmenopausal Women
In the double-blind, placebo controlled study, scientists at VitaK and the Cardiovascular Research Institute (CARIM), both at Maastricht University, The Netherlands, tested whether high vitamin K2 intake promoted bone mineral density and bone strength, determining that supplemental vitamin K2 improved bone mineral content and femoral neck width, but not bone mineral density.
- study In Osteoporosis International Indicates Vitamin K2 Supplementation Improves Hip Bone Geometry and Bone Strength Indices in Postmenopausal Women
In the double-blind, placebo controlled study, scientists at VitaK and the Cardiovascular Research Institute (CARIM), both at Maastricht University, The Netherlands, tested whether high vitamin K2 intake promoted bone mineral density and bone strength, determining that supplemental vitamin K2 improved bone mineral content and femoral neck width, but not bone mineral density.
- study In Osteoporosis International Indicates Vitamin K2 Supplementation Improves Hip Bone Geometry and Bone Strength Indices in Postmenopausal Women
In the double-blind, placebo controlled study, scientists at VitaK and the Cardiovascular Research Institute (CARIM), both at Maastricht University, The Netherlands, tested whether high vitamin K2 intake promoted bone mineral density and bone strength, determining that supplemental vitamin K2 improved bone mineral content and femoral neck width, but not bone mineral density.
- study In Osteoporosis International Indicates Vitamin K2 Supplementation Improves Hip Bone Geometry and Bone Strength Indices in Postmenopausal Women
In the double-blind, placebo controlled study, scientists at VitaK and the Cardiovascular Research Institute (CARIM), both at Maastricht University, The Netherlands, tested whether high vitamin K2 intake promoted bone mineral density and bone strength, determining that supplemental vitamin K2 improved bone mineral content and femoral neck width, but not bone mineral density.
- study In Osteoporosis International Indicates Vitamin K2 Supplementation Improves Hip Bone Geometry and Bone Strength Indices in Postmenopausal Women
In the double-blind, placebo controlled study, scientists at VitaK and the Cardiovascular Research Institute (CARIM), both at Maastricht University, The Netherlands, tested whether high vitamin K2 intake promoted bone mineral density and bone strength, determining that supplemental vitamin K2 improved bone mineral content and femoral neck width, but not bone mineral density.
- Plant-derived omega-3s may aid in bone health
In a small scale study, Penn State researchers have determined that plant-based omega-3 polyunsaturated fatty acids (PUFA) may have a protective effect on bone health
- Plant-derived omega-3s may aid in bone health
In a small scale study, Penn State researchers have determined that plant-based omega-3 polyunsaturated fatty acids (PUFA) may have a protective effect on bone health
- Plant-derived omega-3s may aid in bone health
In a small scale study, Penn State researchers have determined that plant-based omega-3 polyunsaturated fatty acids (PUFA) may have a protective effect on bone health
- Study: Dietary calcium is better than supplements at protecting bone health
Research published in the American Journal of Clinical Nutrition involved a study of 183 postmenopausal women asked to meticulously detail their diet and their calcium supplement intake for a week. A "supplement group," got at least 70 percent of their daily calcium from tablets or pills; "diet group," got at least 70 percent of their calcium from dairy products and other foods; "diet plus supplement group," consisted of those whose calcium-source percentages fell somewhere in between these ranges. The researchers observed that the "diet group" took in the least calcium, an average of 830 milligrams per day. Yet this group had higher bone density in their spines and hipbones than women in the "supplement group,."
- Study: Dietary calcium is better than supplements at protecting bone health
Research published in the American Journal of Clinical Nutrition involved a study of 183 postmenopausal women asked to meticulously detail their diet and their calcium supplement intake for a week. A "supplement group," got at least 70 percent of their daily calcium from tablets or pills; "diet group," got at least 70 percent of their calcium from dairy products and other foods; "diet plus supplement group," consisted of those whose calcium-source percentages fell somewhere in between these ranges. The researchers observed that the "diet group" took in the least calcium, an average of 830 milligrams per day. Yet this group had higher bone density in their spines and hipbones than women in the "supplement group,."
- Study: Dietary calcium is better than supplements at protecting bone health
Research published in the American Journal of Clinical Nutrition involved a study of 183 postmenopausal women asked to meticulously detail their diet and their calcium supplement intake for a week. A "supplement group," got at least 70 percent of their daily calcium from tablets or pills; "diet group," got at least 70 percent of their calcium from dairy products and other foods; "diet plus supplement group," consisted of those whose calcium-source percentages fell somewhere in between these ranges. The researchers observed that the "diet group" took in the least calcium, an average of 830 milligrams per day. Yet this group had higher bone density in their spines and hipbones than women in the "supplement group,."
- Clinical Study Validates that Jarrow Formulas® Bone-Up® Improves Bone Health in Young Women
An 8-week double-blind placebo controlled study using 24 female students ages 18 to 24 who had not done recent, regular resistance exercise followed an 8-week resistance exercise program and also consumed either a placebo or Bone-Up®. Upon comparing data from before and after the 8-week study intervention, Bone-Up® treatment (not placebo) was found to produce statistically significant changes in urinary DPD and alpha-helical peptide (markers of bone degradation), plasma bone specific alkaline phosphatase (a marker of bone synthesis), plasma 2,5-OH-vitamin D (an indicator of vitamin D nutritional status) and plasma parathyroid hormone
- Clinical Study Validates that Jarrow Formulas® Bone-Up® Improves Bone Health in Young Women
An 8-week double-blind placebo controlled study using 24 female students ages 18 to 24 who had not done recent, regular resistance exercise followed an 8-week resistance exercise program and also consumed either a placebo or Bone-Up®. Upon comparing data from before and after the 8-week study intervention, Bone-Up® treatment (not placebo) was found to produce statistically significant changes in urinary DPD and alpha-helical peptide (markers of bone degradation), plasma bone specific alkaline phosphatase (a marker of bone synthesis), plasma 2,5-OH-vitamin D (an indicator of vitamin D nutritional status) and plasma parathyroid hormone
- Clinical Study Validates that Jarrow Formulas® Bone-Up® Improves Bone Health in Young Women
An 8-week double-blind placebo controlled study using 24 female students ages 18 to 24 who had not done recent, regular resistance exercise followed an 8-week resistance exercise program and also consumed either a placebo or Bone-Up®. Upon comparing data from before and after the 8-week study intervention, Bone-Up® treatment (not placebo) was found to produce statistically significant changes in urinary DPD and alpha-helical peptide (markers of bone degradation), plasma bone specific alkaline phosphatase (a marker of bone synthesis), plasma 2,5-OH-vitamin D (an indicator of vitamin D nutritional status) and plasma parathyroid hormone
- Calcium Supplementation Reduces Risk Of Bone Fracture and Bone Loss In Older People
Calcium supplementation alone, or in combination with vitamin D supplementation, reduces the risk of fractures in people aged over 50 by 12%, conclude authors of an Article published in this week’s edition of The Lancet.
- Calcium Supplementation Reduces Risk Of Bone Fracture and Bone Loss In Older People
Calcium supplementation alone, or in combination with vitamin D supplementation, reduces the risk of fractures in people aged over 50 by 12%, conclude authors of an Article published in this week’s edition of The Lancet.
- Calcium Supplementation Reduces Risk Of Bone Fracture and Bone Loss In Older People
Calcium supplementation alone, or in combination with vitamin D supplementation, reduces the risk of fractures in people aged over 50 by 12%, conclude authors of an Article published in this week’s edition of The Lancet.
- Calcium Supplementation Reduces Risk Of Bone Fracture and Bone Loss In Older People
Calcium supplementation alone, or in combination with vitamin D supplementation, reduces the risk of fractures in people aged over 50 by 12%, conclude authors of an Article published in this week’s edition of The Lancet.
- Tea Time: The World’s Favorite Beverage Helps Build Strong Bones
- Tea Time: The World’s Favorite Beverage Helps Build Strong Bones
- Tea Time: The World’s Favorite Beverage Helps Build Strong Bones
- Tea Time: The World’s Favorite Beverage Helps Build Strong Bones
- Vitamin K Status in Children Improves Bone Health in New Study
Research published online at the British Journal of Nutrition link describes how researchers followed 307 healthy children, with an average age of 11.2 years, over a two year period and measured skeletal bone mineral content, finding that improved status of the K vitamins over the two year period resulted in better mineral content and improved bone mass of the whole body.
- Vitamin K Status in Children Improves Bone Health in New Study
Research published online at the British Journal of Nutrition link describes how researchers followed 307 healthy children, with an average age of 11.2 years, over a two year period and measured skeletal bone mineral content, finding that improved status of the K vitamins over the two year period resulted in better mineral content and improved bone mass of the whole body.
- Vitamin K Status in Children Improves Bone Health in New Study
Research published online at the British Journal of Nutrition link describes how researchers followed 307 healthy children, with an average age of 11.2 years, over a two year period and measured skeletal bone mineral content, finding that improved status of the K vitamins over the two year period resulted in better mineral content and improved bone mass of the whole body.
- New Study: Pycnogenol(R) Improves Memory in Elderly
New research accepted for publication in the Journal of Psychopharmacology, indicates that Pycnogenol(R) improved both numerical working memory as well as spatial working memory using a computerized testing system.
- New Study: Pycnogenol(R) Improves Memory in Elderly
New research accepted for publication in the Journal of Psychopharmacology, indicates that Pycnogenol(R) improved both numerical working memory as well as spatial working memory using a computerized testing system.
- New Study: Pycnogenol(R) Improves Memory in Elderly
New research accepted for publication in the Journal of Psychopharmacology, indicates that Pycnogenol(R) improved both numerical working memory as well as spatial working memory using a computerized testing system.
- Natural Vitamin K2 Intake Associated With Reduced Risk Of Hip Fractures In New Japanese Study
A new study linking vitamin K2 to bone health appeared in the European Journal of Epidemiology (2008, 23:219-225, with results indicating that dietary vitamin K2 intake, especially from the food natto (menaquinone-7; MK-7), is associated with a significantly decreased risk of hip fracture.
- Natural Vitamin K2 Intake Associated With Reduced Risk Of Hip Fractures In New Japanese Study
A new study linking vitamin K2 to bone health appeared in the European Journal of Epidemiology (2008, 23:219-225, with results indicating that dietary vitamin K2 intake, especially from the food natto (menaquinone-7; MK-7), is associated with a significantly decreased risk of hip fracture.
- Natural Vitamin K2 Intake Associated With Reduced Risk Of Hip Fractures In New Japanese Study
A new study linking vitamin K2 to bone health appeared in the European Journal of Epidemiology (2008, 23:219-225, with results indicating that dietary vitamin K2 intake, especially from the food natto (menaquinone-7; MK-7), is associated with a significantly decreased risk of hip fracture.
- Vitamin D a Bone Booster for People with Digestive Problems
People with digestive diseases, such as ulcerative colitis and Crohn’s disease, are especially susceptible to osteoporosis and bone fractures, due in part to nutrient deficiencies caused by malabsorption and medication side effects. A new study found that people with good vitamin D status early in the course of their disease had higher bone density and a greater likelihood of increasing bone density over time.
- Vitamin D a Bone Booster for People with Digestive Problems
People with digestive diseases, such as ulcerative colitis and Crohn’s disease, are especially susceptible to osteoporosis and bone fractures, due in part to nutrient deficiencies caused by malabsorption and medication side effects. A new study found that people with good vitamin D status early in the course of their disease had higher bone density and a greater likelihood of increasing bone density over time.
- Vitamin D a Bone Booster for People with Digestive Problems
People with digestive diseases, such as ulcerative colitis and Crohn’s disease, are especially susceptible to osteoporosis and bone fractures, due in part to nutrient deficiencies caused by malabsorption and medication side effects. A new study found that people with good vitamin D status early in the course of their disease had higher bone density and a greater likelihood of increasing bone density over time.
- Vitamin D a Bone Booster for People with Digestive Problems
People with digestive diseases, such as ulcerative colitis and Crohn’s disease, are especially susceptible to osteoporosis and bone fractures, due in part to nutrient deficiencies caused by malabsorption and medication side effects. A new study found that people with good vitamin D status early in the course of their disease had higher bone density and a greater likelihood of increasing bone density over time.
- Vitamin D a Bone Booster for People with Digestive Problems
People with digestive diseases, such as ulcerative colitis and Crohn’s disease, are especially susceptible to osteoporosis and bone fractures, due in part to nutrient deficiencies caused by malabsorption and medication side effects. A new study found that people with good vitamin D status early in the course of their disease had higher bone density and a greater likelihood of increasing bone density over time.
- Vitamin D a Bone Booster for People with Digestive Problems
People with digestive diseases, such as ulcerative colitis and Crohn’s disease, are especially susceptible to osteoporosis and bone fractures, due in part to nutrient deficiencies caused by malabsorption and medication side effects. A new study found that people with good vitamin D status early in the course of their disease had higher bone density and a greater likelihood of increasing bone density over time.
- Vitamin D a Bone Booster for People with Digestive Problems
People with digestive diseases, such as ulcerative colitis and Crohn’s disease, are especially susceptible to osteoporosis and bone fractures, due in part to nutrient deficiencies caused by malabsorption and medication side effects. A new study found that people with good vitamin D status early in the course of their disease had higher bone density and a greater likelihood of increasing bone density over time.
- GTC Nutrition Announces a New Published Study on NutraFlora® Prebiotic Fiber
GTC Nutrition has announced the recent publication of a new study in the journal Nutrition Research relating to NutraFlora® short-chain fructooligosaccharides (scFOS®) prebiotic fiber and the absorption of magnesium
- GTC Nutrition Announces a New Published Study on NutraFlora® Prebiotic Fiber
GTC Nutrition has announced the recent publication of a new study in the journal Nutrition Research relating to NutraFlora® short-chain fructooligosaccharides (scFOS®) prebiotic fiber and the absorption of magnesium
- GTC Nutrition Announces a New Published Study on NutraFlora® Prebiotic Fiber
GTC Nutrition has announced the recent publication of a new study in the journal Nutrition Research relating to NutraFlora® short-chain fructooligosaccharides (scFOS®) prebiotic fiber and the absorption of magnesium
- GTC Nutrition Announces a New Published Study on NutraFlora® Prebiotic Fiber
GTC Nutrition has announced the recent publication of a new study in the journal Nutrition Research relating to NutraFlora® short-chain fructooligosaccharides (scFOS®) prebiotic fiber and the absorption of magnesium
- GTC Nutrition Announces a New Published Study on NutraFlora® Prebiotic Fiber
GTC Nutrition has announced the recent publication of a new study in the journal Nutrition Research relating to NutraFlora® short-chain fructooligosaccharides (scFOS®) prebiotic fiber and the absorption of magnesium
- GTC Nutrition Announces a New Published Study on NutraFlora® Prebiotic Fiber
GTC Nutrition has announced the recent publication of a new study in the journal Nutrition Research relating to NutraFlora® short-chain fructooligosaccharides (scFOS®) prebiotic fiber and the absorption of magnesium
- GTC Nutrition Announces a New Published Study on NutraFlora® Prebiotic Fiber
GTC Nutrition has announced the recent publication of a new study in the journal Nutrition Research relating to NutraFlora® short-chain fructooligosaccharides (scFOS®) prebiotic fiber and the absorption of magnesium
- Gelita Announces Latest Osteoarthritis Research Findings
GELITA has announced the results of two clinical trials regarding their Fortigel product. The research was conducted by Harvard Medical School and Tufts Medical Center, and the Kiel-based Collagen Research Institute of Kiel University.
- Gelita Announces Latest Osteoarthritis Research Findings
GELITA has announced the results of two clinical trials regarding their Fortigel product. The research was conducted by Harvard Medical School and Tufts Medical Center, and the Kiel-based Collagen Research Institute of Kiel University.
- Gelita Announces Latest Osteoarthritis Research Findings
GELITA has announced the results of two clinical trials regarding their Fortigel product. The research was conducted by Harvard Medical School and Tufts Medical Center, and the Kiel-based Collagen Research Institute of Kiel University.
- Gelita Announces Latest Osteoarthritis Research Findings
GELITA has announced the results of two clinical trials regarding their Fortigel product. The research was conducted by Harvard Medical School and Tufts Medical Center, and the Kiel-based Collagen Research Institute of Kiel University.
- Gelita Announces Latest Osteoarthritis Research Findings
GELITA has announced the results of two clinical trials regarding their Fortigel product. The research was conducted by Harvard Medical School and Tufts Medical Center, and the Kiel-based Collagen Research Institute of Kiel University.
- Gelita Announces Latest Osteoarthritis Research Findings
GELITA has announced the results of two clinical trials regarding their Fortigel product. The research was conducted by Harvard Medical School and Tufts Medical Center, and the Kiel-based Collagen Research Institute of Kiel University.
- Gelita Announces Latest Osteoarthritis Research Findings
GELITA has announced the results of two clinical trials regarding their Fortigel product. The research was conducted by Harvard Medical School and Tufts Medical Center, and the Kiel-based Collagen Research Institute of Kiel University.
- GELITA Presents Latest Osteoarthritis Research Findings at FIE
Gelita has announced the latest research findings in regards to their Fortigel product.
- GELITA Presents Latest Osteoarthritis Research Findings at FIE
Gelita has announced the latest research findings in regards to their Fortigel product.
- GELITA Presents Latest Osteoarthritis Research Findings at FIE
Gelita has announced the latest research findings in regards to their Fortigel product.
- GELITA Presents Latest Osteoarthritis Research Findings at FIE
Gelita has announced the latest research findings in regards to their Fortigel product.
- GELITA Presents Latest Osteoarthritis Research Findings at FIE
Gelita has announced the latest research findings in regards to their Fortigel product.
- GELITA Presents Latest Osteoarthritis Research Findings at FIE
Gelita has announced the latest research findings in regards to their Fortigel product.
- GELITA Presents Latest Osteoarthritis Research Findings at FIE
Gelita has announced the latest research findings in regards to their Fortigel product.
- ESM Technologies Presenting on Joint and Bone Health Ingredients in Las Vegas
ESM Technologies has announced they will be presenting "Joint Health in Record Time: Clinically Effective Results from NEM(R) in 10 days," in Las Vegas, Friday, November 13, at 2:30 pm.
- ESM Technologies Presenting on Joint and Bone Health Ingredients in Las Vegas
ESM Technologies has announced they will be presenting "Joint Health in Record Time: Clinically Effective Results from NEM(R) in 10 days," in Las Vegas, Friday, November 13, at 2:30 pm.
- ESM Technologies Presenting on Joint and Bone Health Ingredients in Las Vegas
ESM Technologies has announced they will be presenting "Joint Health in Record Time: Clinically Effective Results from NEM(R) in 10 days," in Las Vegas, Friday, November 13, at 2:30 pm.
- ESM Technologies Presenting on Joint and Bone Health Ingredients in Las Vegas
ESM Technologies has announced they will be presenting "Joint Health in Record Time: Clinically Effective Results from NEM(R) in 10 days," in Las Vegas, Friday, November 13, at 2:30 pm.
- ESM Technologies Presenting on Joint and Bone Health Ingredients in Las Vegas
ESM Technologies has announced they will be presenting "Joint Health in Record Time: Clinically Effective Results from NEM(R) in 10 days," in Las Vegas, Friday, November 13, at 2:30 pm.
- ESM Technologies Presenting on Joint and Bone Health Ingredients in Las Vegas
ESM Technologies has announced they will be presenting "Joint Health in Record Time: Clinically Effective Results from NEM(R) in 10 days," in Las Vegas, Friday, November 13, at 2:30 pm.
- ESM Technologies Presenting on Joint and Bone Health Ingredients in Las Vegas
ESM Technologies has announced they will be presenting "Joint Health in Record Time: Clinically Effective Results from NEM(R) in 10 days," in Las Vegas, Friday, November 13, at 2:30 pm.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Basel, Switzerland, July 31st, 2008 – A new study released by the University of Connecticut, USA, suggests, that Carnipure™ tartrate supplementation can slow down bone loss and improve bone microstructural properties by decreasing bone turnover in aged ovariectomized rats. The study was supported by Lonza, utilizing its Carnipure™ tartrate which is a very stable salt form of L-Carnitine. The findings were published in the June 2008 issue of Phytomedicine.
L-Carnitine plays a central role in energy metabolism and is especially important for tissues with high energy requirements, such as the skeletal muscles or the heart. It has been demonstrated that L-Carnitine levels decrease with age and its deficiency compromises the utilization of energy, as well as physical performance. A few studies have also led to the conclusion that L-Carnitine can have a beneficial effect on bone.
Ovariectomized rats serve as a model to study postmenopausal bone metabolism. A major public health concern in postmenopausal bone loss is caused by an increased rate of bone turnover. When the rate of bone resorption exceeds that of bone formation, fracture risk is increased.
In this study, ovariectomized female rats were assigned to two different groups, one received a diet without L-Carnitine supplementation and the other received the same diet plus Carnipure™ tartrate supplementation during a 5 week period. Different dietary treatments did not significantly affect food intake or body weight, although there was a tendency of lower body weight in the Carnipure™ tartrate supplemented group. Mean tibial bone mineral density of the Carnipure™ tartrate supplemented rats was significantly higher, 6.3% compared to the control group. This is considered clinically relevant when the results are compared with certain approved medications for osteoporosis. Carnipure™ tartrate supplementation was further found to decrease gene expressions of TRAP, a measure of bone resorption, by 72.8% while also decreasing two markers of bone formation by over 60%, compared with the control group.
“These findings indicate that Carnipure™ tartrate supplementation can suppress the rate of bone turnover, which also adds to the growing body of evidence supporting the potential use of Carnipure™ tartrate in post-menopausal women”, says Mike DeGennaro, Global Head Marketing & Sales Nutrition at Lonza.
Lonza is the only manufacturer of the Carnipure™ brand of L-Carnitine products including Carnipure™ tartrate (U.S. Patent 5073376, Japan Patent JP 2546068 and other international patents). Carnipure™ tartrate consists of 68% pure L-Carnitine and 32% L-tartaric acid and is self affirmed as GRAS (Generally Recognized as Safe). Carnipure™ products are crystalline, white, water-soluble and heat stable which makes them ideal for use in various food and drink applications. In addition, Carnipure™ tartrate is non-hygroscopic, odorless, has a pleasant citrus taste and excellent flowability. Carnipure™ products are kosher certified. Further details are available at www.carnipure.com.
About Lonza
Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers’ needs from research to final product manufacture. Lonza is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Lonza is also a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.
Lonza is headquartered in Basel, Switzerland and is listed on the SWX Swiss Exchange. In 2007, Lonza had sales of CHF 2.87 billion. Further information can be found at www.lonza.com.
|